NCT06061614View on ClinicalTrials.gov

Safety and Efficacy Study of NGGT002 in PKU Adult Subjects

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

9

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2028

Conditions

Phenylketonurias

Interventions

GENETIC

NGGT002

NGGT002

Trial Locations (1)

233000

RECRUITING

The First Affiliated Hospital of Bengbu Medical College, Bengbu

All Listed Sponsors

lead

The First Affiliated Hospital of Bengbu Medical University

OTHER